Drugs / fosnetupitant

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) AKYNZEO 2018-04-19 fda.gov

Trials 3 · a red edge is where a trial was stopped

20182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT06840769 Jun → Oct 2023 Helsinn Healthcare SA Terminated No outcome recorded
Phase 21 trial
Phase 2 NCT06904235 Jul 2025 → Oct 2027 expected chemotherapy-induced toxicity Helsinn Healthcare SA Recruiting No outcome recorded
Phase 31 trial
Phase 3 NCT03403712 Mar → Sep 2018 chemotherapy-induced toxicity Helsinn Healthcare SA Completed No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as fosnetupitant ClinicalTrials.gov intervention name — accepted as the source's own label NCT06904235
2

NCT03403712

NCT06840769

Known as 07-PNET ChEMBL registry synonym — accepted as the source's own label CHEMBL3989917
Known as 08-PNET ChEMBL registry synonym — accepted as the source's own label CHEMBL3989917
Known as Fosnetupitant chloride ChEMBL registry synonym — accepted as the source's own label CHEMBL3989917
Known as FOSNETUPITANT CHLORIDE HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL3989917
Known as Fosnetupitant chloride hydrochloride component of akynzeo ChEMBL registry synonym — accepted as the source's own label CHEMBL3989917
Known as Fosnetupitant chloride hydrochloride component of akynzeo for injection ChEMBL registry synonym — accepted as the source's own label CHEMBL3989917
Known as Fosnetupitant dihydrochloride ChEMBL registry synonym — accepted as the source's own label CHEMBL3989917
Action Inhibit “fosnetupitant, an antagonist of NK1 receptors” NCT06904235
1

“Neurokinin 1 receptor antagonist” CHEMBL3989917

Modality Small molecule CHEMBL3989917
Route Intravenous intravenous fosnetupitant/ palonosetron” NCT03403712
Target TACR1 “Neurokinin 1 receptor antagonist” CHEMBL3989917